Results 201 to 210 of about 143,561 (278)

Minimally invasive surgical treatment of recurrent endometrial carcinoma: A systematic review

International Journal of Gynecology &Obstetrics, Volume 172, Issue 2, Page 866-878, February 2026.
Abstract Background While the role minimally invasive surgery (MIS) is established for primary endometrial carcinoma (EC), its feasibility in recurrent cases remains underexplored. Objective To systematically review the literature about MIS for EC recurrence.
Antonio Raffone, Daniele Neola, Alessio Colalillo, Claudia Tucci, Diego Raimondo, Antonio Travaglino, Maria Giovanna Vastarella, Massimiliano Fambrini, Maurizio Guida, Silvia D'Ippolito, Renato Seracchioli, Luigi Cobellis, Francesco Cosentino   +12 more
wiley   +1 more source

The performance of DWI and ADC values with different b-values for the diagnosis and staging of endometrial carcinoma at 3T. [PDF]

Cancer Imaging
Deng Y, Bi Q, Wang Q, Wang J, Yang H, Ding F, Li Q, Wang Q, Wu K.   +8 more
europepmc   +1 more source

Radiogenomics: Current Understandings and Future Perspectives

MedComm, Volume 7, Issue 2, February 2026.
Radiogenomics links imaging phenotypes with genetic variations, offering potential for comprehensive understanding, cost‐effective diagnosis, and prognosis prediction to advance personalized medicine. However, its clinical application remains limited by several challenges.
Xinyu Zhang, Qingpei Lai, Jin Cao, Jerry Chi Fung Ching, Xinzhi Teng, Jiang Zhang, Shara Wee Yee Lee, Ge Ren, Jing Cai   +8 more
wiley   +1 more source

The immune microenvironment in endometrial carcinoma: mechanisms and therapeutic targeting. [PDF]

Front Immunol
Wang Y, Liu N, Guo X, Han R, Bai J, Zhong J, Wang Q.   +6 more
europepmc   +1 more source

Natural Products in Cancer Prevention and Therapy: Current Challenges and Future Directions

MedComm, Volume 7, Issue 2, February 2026.
Natural products play a pivotal role in cancer therapy. They induce cancer cell death by reprogramming four metabolic pathways while precisely targeting the tumor microenvironment and immune cells. These compounds not only leverage novel delivery systems for innovative applications but also demonstrate unique therapeutic efficacy across clinical stages:
Ruimiao Qian, Jun Ge, Ni Fan, Zheng Sun, Chengcheng Zhao, Yujiao Sun, Yingpeng Li, Yunfei Li, Hui Fu   +8 more
wiley   +1 more source

Fertility Preservation in Early-Stage Endometrial Carcinoma and EIN: A Single-Centre Experience and Literature Review. [PDF]

Cancers (Basel)
Krasznai ZT, Hajagos E, Kiss VG, Damjanovich P, Tóth S, Molnár S.   +5 more
europepmc   +1 more source

Tumor‐Associated Macrophages as Therapeutic Targets: Deciphering Interaction Networks and Advancing Clinical Translation

MedComm, Volume 7, Issue 2, February 2026.
Tumor‐associated macrophages are the most abundant immune cells in the tumor microenvironment, driving malignant progression and treatment resistance. This review summarizes the protumor mechanisms of TAMs (including phagocytosis modulation, metabolic reprogramming, exosomal communication, and immune interactions), evaluates three major strategies ...
Wurihan Bao, Xiaojie Qu, Yiqi Wang, Dan Huang, Huiling Zhang, Mingyuan Dong, Han Sun, Zhaogang Yang, Xuefeng Li   +8 more
wiley   +1 more source

Stem cell engineering for the generation of allogeneic CAR-directed natural killer T cells targeting endometrial carcinoma. [PDF]

Exp Hematol Oncol
Li YR, DiBernardo GA, Chen Y, Shen X, Hon R, Ruegg LE, Huang J, Neal A, Moatamed NA, Memarzadeh S, Yang L.   +10 more
europepmc   +1 more source

Single‐nucleus RNA sequencing identifies a novel tenogenic heterologous differentiation in endometrial carcinosarcomas: implications for diagnosis and tumor classification

The Journal of Pathology, Volume 268, Issue 2, Page 227-242, February 2026.
Abstract Carcinosarcomas (CSs) are aggressive biphasic tumors characterized by epithelial and mesenchymal components, whose histogenesis and differentiation dynamics remain poorly understood. We present single‐nucleus RNA sequencing (snRNA‐seq) analysis of six CSs (five endometrial and one ovarian) and two normal endometrial samples, profiling over 96 ...
Silvia González‐Martínez, José Palacios, Irene Carretero‐Barrio, Val Fernández‐Lanza, Alfonso Cortés‐Salgado, Javier Román, Xavier Matias‐Guiu, Sonia Gatius, Javier Cortés, Belén Pérez‐Mies   +9 more
wiley   +1 more source

Development and validation of a prognostic model for endometrial carcinoma using causal genes identified by Mendelian randomization. [PDF]

Medicine (Baltimore)
Yang D, Li Y, Xin X, Ma H.
europepmc   +1 more source